FDA-cleared UltraClear laser arrives in UK; patient reports 10-year improvement in neck appearance

An FDA-cleared noninvasive laser system called UltraClear has begun to be offered in the United Kingdom, and a 52‑year‑old beauty journalist who underwent the procedure reported that her neck looked about 10 years younger after two months.

The device combines short, concentrated light pulses that ablate the skin’s surface with deeper thermal energy intended to stimulate collagen and elastin production. Aesthetic clinician Dr. Mervyn Patterson of Woodford Medical clinics said the neck is prone to earlier ageing because it has thinner skin, fewer oil glands and is subject to near‑constant movement and sun exposure. "Add in sun exposure, 'tech‑neck' from staring at our phones and laptops, as well as a general lack of attention (when did you last apply SPF to your neck?), and it’s no wonder it ends up looking older than the rest of you," he said.

Manufacturers and clinicians describe UltraClear as a "cold laser" system, designed to minimise heat build‑up in the epidermis while allowing deeper thermal delivery. The treatment has multiple settings; the manufacturer and clinicians refer to a high‑intensity setting called Laser‑Coring that performs precision micro‑stamping to remove tiny sections of the top skin layer, and gentler settings such as 3D Miracl for facial use. The combination of controlled surface injury and deeper heating is intended to trigger the body’s natural healing response and new collagen formation, producing firmer, smoother skin over weeks to months.

The journalist described the procedure as the most invasive "facial" she had experienced without surgery. Topical lidocaine numbing cream was applied for 30 minutes before treatment. A handheld nozzle resembling a miniature stamp was moved across the face for roughly 20 minutes and across the front, sides of the neck and decolletage for about 30 minutes. Clinicians placed a sterile, cool cellulose‑and‑water mask — known as a Velez mask — on the treated area immediately after the session to reduce heat.

Immediate side effects reported in the account included visible pinpoint bleeding, a mesh‑like pattern on the skin, marked redness and swelling comparable to severe sunburn, and a faint burning smell during treatment. The treated area remained sun‑sensitive, and clinicians advised avoiding direct sunlight for two weeks and using high‑factor sunscreen.

During the subsequent days the treated skin peeled, and the patient experienced an intense itching sensation on the neck that disrupted sleep and was partially managed with oral antihistamines. A post‑procedure topical cream containing copper peptides (Neova Cu3 Tissue Repair Cream) was used several times daily to moisturise and aid healing. The journalist said she looked almost back to normal after about a week, but it took roughly 10 days before she felt comfortable exposing her neck in public.

Clinicians say downtime and reactions vary by setting and patient. The cold‑laser approach is intended to reduce swelling and recovery time compared with traditional ablative lasers, but the Laser‑Coring setting used on the neck produces more visible surface injury and a longer visible recovery than gentler settings used on the face.

The journalist reported that two months after treatment the neck’s pigmentation had faded, skin texture had smoothed and loose folds had diminished. Clinicians and the device maker say results can be seen progressively as collagen remodels, and treatments are sometimes repeated after two to three months with maintenance sessions possible every 12 to 18 months.

UltraClear has been marketed to treat laxity, pigment and skin texture on the neck, face and decolletage. Pricing reported by the clinic in the account started at about £950. The treatment is available at selected clinics in the UK; clinicians cited websites including woodfordmedical.com and ultraclearlaser.com for more information.

The arrival of UltraClear adds to a range of non‑surgical options for neck rejuvenation. Injectable neuromodulators such as botulinum toxin can relax the platysma muscle and reduce vertical banding. Energy‑based devices including ultrasound‑based Ultherapy and radiofrequency microneedling systems such as Morpheus8 are commonly offered for skin lifting and collagen induction; these services have varied price points and clinical profiles. Over‑the‑counter topical products and consumer devices remain widely marketed for neck care, and some patients also try external support garments or "shapewear" intended to create temporary contouring.

Clinicians caution that noninvasive and minimally invasive options carry different balances of efficacy, downtime and risk, and that patients should consider sun exposure, skin type and medical history when choosing treatment. The account and clinician commentary emphasise that treated skin is hyper‑sensitive to sunlight in the immediate weeks following resurfacing, and strict sun protection is recommended to reduce the risk of pigmentation changes.

Health regulators in the UK and the United States have increasingly overseen marketing and clearance of aesthetic devices. UltraClear is described by promoters as FDA‑cleared for specific indications; patients and prospective users should seek consultation with accredited and experienced practitioners to discuss expected outcomes, risks and aftercare prior to undergoing treatment.